Vincent Lo Re, MD, MSCE is Associate Professor of Medicine (Infectious Diseases) and Epidemiology at the University of Pennsylvania, Senior Scholar in the Penn Center for Clinical Epidemiology and Biostatistics, and Co-Director of the Penn Center for AIDS Research HIV/Viral Hepatitis Scientific Working Group. Dr. Lo Re leads a nationally recognized research program that examines the epidemiology of acute and chronic liver diseases in HIV-infected patients. He has conducted population-based and mechanistic studies that have helped to move the field of chronic viral hepatitis and HIV/viral hepatitis coinfection forward in a unique way. Recent research has evaluated end-stage liver disease and liver cancer events among HIV/hepatitis C-coinfected patients; examined how chronic viral hepatitis and HIV/viral hepatitis coinfection influence extra-hepatic outcomes, particularly metabolic bone disease; determined the impact that medications have on acute liver injury and progression of chronic viral hepatitis; and evaluated adherence and adverse effects of antiviral therapies of chronic hepatitis B and C.
He has particular expertise in evaluating liver-related and other health outcomes among viral hepatitis-infected patients within large electronic data sources, such as the Veterans Health Administration, Kaiser Permanente Northern California, U.S. Medicaid, U.S. Medicare, and Sentinel. His research has been funded by the National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, Agency for Healthcare Research and Quality, Department of Veterans Affairs, and the U.S. Food and Drug Administration. Additionally, Dr. Lo Re has been a standing member of FDA’s Antiviral Drug (now Anti-Infective) Advisory Committee since 2014 and co-chair of the Liver Core of the Veterans Aging Cohort Study since 2009. He maintains an active clinical practice devoted to the care of patients with chronic viral hepatitis, particularly those coinfected with HIV.